SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001016169-08-000064
Filing Date
2008-10-14
Accepted
2008-10-14 14:55:39
Documents
4
Period of Report
2008-10-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 k8lenandpaul.htm 8-K 39760
2 MANAGEMENT CHANGE wotton.htm EX-99 10374
3 GRAPHIC img1.jpg GRAPHIC 3740
4 BOARD CHANGE len.htm EX-99 10370
  Complete submission text file 0001016169-08-000064.txt   67686
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 081121985
SIC: 3841 Surgical & Medical Instruments & Apparatus